pentobarbital has been researched along with Hypertension, Malignant in 2 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
OLMER, J | 1 |
CARCASSONNE, Y | 1 |
Miura, Y | 1 |
2 other studies available for pentobarbital and Hypertension, Malignant
Article | Year |
---|---|
[MALIGNANT ARTERIAL HYPERTENSION: PROLONGED EFFECTS OF SLEEP THERAPY].
Topics: Chlorpromazine; Hypertension; Hypertension, Malignant; Pentobarbital; Promethazine; Sleep | 1964 |
Improved method for measurement of renin activity in human plasma.
Topics: Angiotensin II; Animals; Biological Assay; Blood Pressure; Chromatography; Edetic Acid; Female; Huma | 1969 |